Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-13ACHV3Form 3 Filing for Achieve Life Sciences, Inc. Director Christopher Martin
This filing is a Form 3, which reports initial beneficial ownership of securities. It indicates that Christopher Martin, a director of Achieve Life Sciences, Inc., has no securities beneficially owned following the reporting period. The filing also includes a Limited Power of Attorney document, appointing Sandra Thomso...
Small CapBiotechnology
2026-05-13ANAB3Power of Attorney for Owen Hughes
This filing relates to a Power of Attorney granted by Owen Hughes, a director of AnaptysBio, Inc., to Daniel Faga and Dave McKeon. The power of attorney authorizes the attorneys-in-fact to execute and file all necessary Form 3, 4, or 5 reports with the SEC and any stock exchange on behalf of Mr. Hughes, in accordance w...
Small CapBiotechnology
2026-05-13ANAB3Power of Attorney Appointment
This filing indicates that Christopher M. Murphy, Chief Financial Officer of AnaptysBio, Inc., has appointed Daniel Faga and Dave McKeon as his attorneys-in-fact. This appointment authorizes them to execute and file all necessary Form 3, 4, or 5 reports with the SEC and any stock exchanges on Mr. Murphy's behalf, in ac...
Small CapBiotechnology